Dr Deborah A Berberich, PHD | |
1210 N. Jefferson Street, Unit F, Anaheim, CO 92807 | |
(714) 398-8491 | |
(714) 961-1512 |
Full Name | Dr Deborah A Berberich |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 1210 N. Jefferson Street, Anaheim, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639450935 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PSY17579 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Deborah A Berberich, PHD 1210 N. Jefferson Street, Unit F, Anaheim, CO 92807 Ph: (714) 398-8491 | Dr Deborah A Berberich, PHD 1210 N. Jefferson Street, Unit F, Anaheim, CO 92807 Ph: (714) 398-8491 |
News Archive
Chemists at Caltech have developed a new sensitive technique capable of detecting colorectal cancer in tissue samples - a method that could one day be used in clinical settings for the early diagnosis of colorectal cancer.
Deadline day arrived Monday for comments on Medicare's much-abused proposal for accountable care organizations. And supporters of the Obama administration championed its pro-patient provisions in the face of criticism from the health industry. Early industry feedback on the ACO rule focused on the expense and complexity it posed for hospitals, doctors and health organizations interested in teaming up to achieve higher quality, better patient care and lower costs.
According to the National Heart, Lung and Blood Institute, the average sleep apnea sufferer stops breathing and loses oxygen between five and 30 times a night. This lack of oxygen leads to a host of complications, including high blood pressure, vascular disease, an abnormal heart rhythm, or even a fatal cardiac event. Now, a team of University of Missouri researchers is exploring the changes in distinct brain regions that contribute to these symptoms in hopes of combating this common health issue.
As genetic testing for breast cancer has become more complex, evaluating a panel of multiple genes, it introduces more uncertainty about the results. But a new study finds that newer, more extensive tests are not causing patients to worry more about their cancer risk.
Researchers from the UC San Diego, School of Medicine and colleagues have identified a new gene, ETS-1, that is linked to human congenital heart defects. The landmark study, recently published online in the journal of Human Molecular Genetics, provides important insights into some of the most prevalent forms of congenital heart defects in humans, including ventricular septal defects and potentially hypoplastic left heart syndrome, a uniformly fatal heart abnormality.
› Verified 5 days ago